Complications encountered with a transfemorally placed port-catheter system for hepatic artery chemotherapy infusion

被引:27
作者
Kuroiwa, T [1 ]
Honda, H [1 ]
Yoshimitsu, K [1 ]
Irie, H [1 ]
Aibe, H [1 ]
Tajima, T [1 ]
Shinozaki, K [1 ]
Masuda, K [1 ]
机构
[1] Kyushu Univ, Grad Sch Med Sci, Dept Clin Radiol, Higashi Ku, Fukuoka 8128582, Japan
关键词
liver cancer; implanted port; transcatheter intraarterial chemotherapy; transcatheter arterial embolization; complication;
D O I
10.1007/s002700000376
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A port-catheter system was implanted via femoral artery access for hepatic artery chemotherapy infusion. Implantation was attempted in 90 patients and was successful in 88. Blood flow redistribution was performed using embolization coils. In the first ten patients a soft heparin-coated infusion catheter was used. For the following 78 patients we used a stiffer catheter coated with fluorine-acryl-styrene-urethane-silicone (FASUS) copolymer. The catheter was connected to a port implanted subcutaneously below the level of the inguinal ligament. Complications during the procedure and after placement were observed in 7 of 90 patients and 24 of 88 patients, respectively. These included catheter obstruction (11%), dislocation of the catheter tip (10%), drug toxicity (5.7%), and catheter infection (3.4%). In 6 of 10 patients with catheter obstruction, recanalization of the port system was achieved. In 7 of 9 patients with dislocation of the indwelling catheter tip, replacement of the port system was successful. Our complications appear to be comparable with those encountered with the subclavian/brachial approach when the new catheter coating is used. Notable is the avoidance of cerebral infarcts.
引用
收藏
页码:90 / 93
页数:4
相关论文
共 17 条
[1]   Intermittent hepatic arterial infusion of high-dose 5FU on a weekly schedule for liver metastases from colorectal cancer [J].
Arai, Y ;
Inaba, Y ;
Takeuchi, Y ;
Ariyoshi, Y .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1997, 40 (06) :526-530
[2]  
ARAI Y, 1988, J NAGOYA CITY U MED, V39, P453
[3]  
FISHER RA, 1995, J GASTROENTEROL, V30, P356
[4]   Complications and technical limitations of hepatic arterial infusion catheter placement for chemotherapy [J].
Habbe, TG ;
McCowan, TC ;
Goertzen, TC ;
Leveen, RF ;
Culp, WC ;
Tempero, MA .
JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 1998, 9 (02) :233-239
[5]   Percutaneous long-term arterial access with implantable ports - Direct subclavian approach with US [J].
Hayashi, N ;
Sakai, T ;
Kitagawa, M ;
Kimoto, T ;
Ishii, Y .
EUROPEAN JOURNAL OF RADIOLOGY, 1998, 26 (03) :304-308
[6]   Percutaneously implantable catheter-port system for chemotherapeutic infusion through the hepatic artery [J].
Jung, HY ;
Shim, HJ ;
Kwak, BK ;
Choi, YH ;
Yoon, SJ ;
Song, IS ;
Choi, YH ;
Kim, YS ;
Lee, JB ;
Lee, YC ;
Kim, KS .
AMERICAN JOURNAL OF ROENTGENOLOGY, 1999, 172 (03) :641-644
[7]  
KAWAHITO K, 1993, HEART REPL ARTIFIC H, V4, P37
[8]   In vivo evaluation of a fluorine-acryl-stylene-urethane-silicone antithrombogenic coating material copolymer for intravascular stents [J].
Matsuhashi, T ;
Miyachi, H ;
Ishibashi, T ;
Sakamoto, K ;
Yamadera, A .
ACADEMIC RADIOLOGY, 1996, 3 (07) :581-588
[9]  
Matsumoto Shunro, 1997, Nippon Acta Radiologica, V57, P238
[10]  
MORITA S, 1996, INTERV RADIOL, V11, P387